Population pharmacokinetic model development and its relationship with adverse events of oxcarbazepine in adult patients with epilepsy
Abstract This study aimed to develop a pharmacokinetic (PK) model of oxcarbazepine (OXC) and analyse the relationship between monohydroxylated derivative (MHD), an active metabolite of OXC, and the adverse events of OXC. We obtained 711 OXC samples from 618 patients with epilepsy who were enrolled i...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/6c0150e2099e43f5a9056c9e990cf932 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|